Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1981 Jan;134(1):11–14.

Bleeding After Liver Biopsy

Anmol S Mahal 1,2,3, Michael Knauer 1,2,3, Peter B Gregory 1,2,3
PMCID: PMC1272443  PMID: 7210659

Abstract

During nine years 3,080 liver biopsies were carried out and bleeding occurred in 22 of the patients (0.7 percent). Transfusions were given to 17 of these patients and laparotomies were done to control the bleeding in six. All survived. Bleeding was evident within three hours in 19 patients, but occurred from 3 to 13 days after biopsy in the remaining three. Pain requiring analgesic medication and a fall in blood pressure were the usual indications that major bleeding had occurred. Relative contraindications to biopsy (particularly a prolonged prothrombin time) were present in 10 of the 22 bleeding patients and in only 2 of the 41 nonbleeding controls (P<0.001). We believe that some of the bleeding episodes could have been prevented with more careful attention to the indications and contraindications to biopsy, and more rigorous correction of recognized clotting abnormalities.

Full text

PDF
11

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Lindner H. Grenzen und Gefahren der perkutanen Leberbiopsie mit der Menghini-Nadel. Erfahrungen bei 80,000 Leberbiopsien. Dtsch Med Wochenschr. 1967 Sep 29;92(39):1751–1757. doi: 10.1055/s-0028-1106036. [DOI] [PubMed] [Google Scholar]
  2. McCloskey R. V., Gold M., Weser E. Bacteremia after liver biopsy. Arch Intern Med. 1973 Aug;132(2):213–215. [PubMed] [Google Scholar]
  3. Menghini G. One-second biopsy of the liver--problems of its clinical application. N Engl J Med. 1970 Sep 10;283(11):582–585. doi: 10.1056/NEJM197009102831107. [DOI] [PubMed] [Google Scholar]
  4. Ovlisen B., Baden H. Leverbiopsi a.m. Menghini. Nord Med. 1970 Mar 5;83(10):297–299. [PubMed] [Google Scholar]
  5. PARETS A. D. Detection of intrahepatic metastases by blind needle liver biopsy. Am J Med Sci. 1959 Mar;237(3):335–340. doi: 10.1097/00000441-195903000-00007. [DOI] [PubMed] [Google Scholar]
  6. Perrault J., McGill D. B., Ott B. J., Taylor W. F. Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology. 1978 Jan;74(1):103–106. [PubMed] [Google Scholar]
  7. Raines D. R., Van Heertum R. L., Johnson L. F. Intrahepatic hematoma: a complication of percutaneous liver biopsy. Gastroenterology. 1974 Aug;67(2):284–289. [PubMed] [Google Scholar]
  8. Spero J. A., Lewis J. H., Van Theil D. H., Hasiba U., Rabin B. S. Asymptomatic structural liver disease in hemophilia. N Engl J Med. 1978 Jun 22;298(25):1373–1378. doi: 10.1056/NEJM197806222982501. [DOI] [PubMed] [Google Scholar]
  9. TERRY R. Risks of needle biopsy of the liver. Br Med J. 1952 May 24;1(4768):1102–1105. doi: 10.1136/bmj.1.4768.1102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. THALER H. UBER VORTEIL UND RISIKO DER LEBERBIOPSIEMETHODE NACH MENGHINI. Wien Klin Wochenschr. 1964 Jul 17;76:533–538. [PubMed] [Google Scholar]
  11. ZAMCHECK N., KLAUSENSTOCK O. Liver biopsy. II. The risk of needle biopsy. N Engl J Med. 1953 Dec 24;249(26):1062–concl. doi: 10.1056/NEJM195312242492605. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES